Author:
Ehrich Elliot,Turncliff Ryan,Du Yangchun,Leigh-Pemberton Richard,Fernandez Emilio,Jones Reese,Fava Maurizio
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference41 articles.
1. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993). Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264: 489–495.
2. Bencherif B, Fuchs PN, Sheth R, Dannals RF, Campbell JN, Frost JJ (2002). Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Pain 99: 589–598.
3. Bodkin JA, Zornberg GL, Lukas SE, Cole JO (1995). Buprenorphine treatment of refractory depression. J Clin Psychopharmacol 15: 49–57.
4. Callaway E (1996). Buprenorphine for depression: the un-adoptable orphan. Biol Psychiatry 39: 989–990.
5. Carlezon WA Jr ., Beguin C, Knoll AT, Cohen BM (2009). Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacol Ther 123: 334–343.
Cited by
135 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献